explore -WSS

explore

author：explore 2025-09-27 23:52:15 - browse：953

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： How faith leaders like me can help address America's obesity epidemic

focus

WSS

My daughter's legacy lives on through her writing, phage therapy

Rise in cancer among younger people worries and puzzles doctors

In the gardens at Boston Children's Hospital, families find sanctuary

What it's like to live with paralysis for one psychologist

Curing rare childhood diseases will falter unless Congress steps up

Dems pitch expanding Medicare power to negotiate drug prices

knowledge

explore

hotspot

New air purifier tech could be key to improving indoor air quality

A new crop of companies is reshaping the health data economy

Heart attack and stroke risk calculators need revising

California wildfire smoke linked to 52,000 early deaths, study says

Heart attack and stroke risk calculators need revising

Curing rare childhood diseases will falter unless Congress steps up

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NIH tests clinical research in primary care with $30 million program

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Former reverend arrested for allegedly killing 8

hotspot

My daughter's legacy lives on through her writing, phage therapy

ALS patient reclaims some autonomy thanks to wearable 'robot'

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Democrats decry new health bill for going easy on private equity

What it's like to live with paralysis for one psychologist

Curing rare childhood diseases will falter unless Congress steps up

focus

leisure time

focus

Wikipedia